Sen. John Fetterman’s term runs through January 2029, and recent activity shows continued engagement in Senate business, including August 2026 bipartisan legislation on infrastructure, agriculture, and regulatory matters alongside Pennsylvania officials. Public statements through mid-2026, including a May Washington Post op-ed and July remarks, affirm no plans to leave the Democratic Party or the Senate absent a major shift on issues such as Israel policy. Staff turnover and earlier health scrutiny have not produced new catalysts for resignation, while 2026 midterm dynamics center on other seats. Trader consensus at roughly 86% for “No” aligns with the lack of procedural, electoral, or personal developments that historically prompt mid-term Senate vacancies.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoSí
15% probabilidad
NUEVO
NUEVO
31 dic 2026
Sí
15% probabilidad
NUEVO
NUEVO
31 dic 2026
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.Sen. John Fetterman’s term runs through January 2029, and recent activity shows continued engagement in Senate business, including August 2026 bipartisan legislation on infrastructure, agriculture, and regulatory matters alongside Pennsylvania officials. Public statements through mid-2026, including a May Washington Post op-ed and July remarks, affirm no plans to leave the Democratic Party or the Senate absent a major shift on issues such as Israel policy. Staff turnover and earlier health scrutiny have not produced new catalysts for resignation, while 2026 midterm dynamics center on other seats. Trader consensus at roughly 86% for “No” aligns with the lack of procedural, electoral, or personal developments that historically prompt mid-term Senate vacancies.
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Mercado abierto: Nov 14, 2025, 7:17 PM ET
Volumen
$1,296Fecha de finalización
31 dic 2026Mercado abierto
Nov 14, 2025, 7:17 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.Sen. John Fetterman’s term runs through January 2029, and recent activity shows continued engagement in Senate business, including August 2026 bipartisan legislation on infrastructure, agriculture, and regulatory matters alongside Pennsylvania officials. Public statements through mid-2026, including a May Washington Post op-ed and July remarks, affirm no plans to leave the Democratic Party or the Senate absent a major shift on issues such as Israel policy. Staff turnover and earlier health scrutiny have not produced new catalysts for resignation, while 2026 midterm dynamics center on other seats. Trader consensus at roughly 86% for “No” aligns with the lack of procedural, electoral, or personal developments that historically prompt mid-term Senate vacancies.
This market will resolve to “Yes” if John Fetterman ceases to be U.S. Senator from Pennsylvania for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of John Fetterman's resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from John Fetterman and the U.S. government; however, a consensus of credible reporting may also be used.
Volumen
$1,296Fecha de finalización
31 dic 2026Mercado abierto
Nov 14, 2025, 7:17 PM ETResolver
0x65070BE91...Sen. John Fetterman’s term runs through January 2029, and recent activity shows continued engagement in Senate business, including August 2026 bipartisan legislation on infrastructure, agriculture, and regulatory matters alongside Pennsylvania officials. Public statements through mid-2026, including a May Washington Post op-ed and July remarks, affirm no plans to leave the Democratic Party or the Senate absent a major shift on issues such as Israel policy. Staff turnover and earlier health scrutiny have not produced new catalysts for resignation, while 2026 midterm dynamics center on other seats. Trader consensus at roughly 86% for “No” aligns with the lack of procedural, electoral, or personal developments that historically prompt mid-term Senate vacancies.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes